128 related articles for article (PubMed ID: 9282675)
1. Angiopathy in diabetes mellitus.
Prusty P; Saini JS; Gandhi B; Prabhakar AR
J Assoc Physicians India; 1995 Feb; 43(2):111-4. PubMed ID: 9282675
[No Abstract] [Full Text] [Related]
2. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
3. [Quality of metabolic management and angiopathy in 180 long-term diabetics with at least 20 years duration of the disease].
Pense G; Panzram G; Pissarek D; Meinhold J; Müller W; Leder H; Kaselow D; Adolph W
Schweiz Med Wochenschr; 1973 Aug; 103(32):1125-9. PubMed ID: 4755043
[No Abstract] [Full Text] [Related]
4. [Diabetes mellitus and blood vessel disorders].
Muth HW
Med Klin; 1968 Feb; 63(5):178-80. PubMed ID: 5670168
[No Abstract] [Full Text] [Related]
5. [Antioxidants in the combined therapy of diabetic angiopathies].
Bobyreva LE
Eksp Klin Farmakol; 1998; 61(1):74-80. PubMed ID: 9575419
[TBL] [Abstract][Full Text] [Related]
6. [Urinary hydroxyproline excretion in diabetes mellitus].
Lohmann D; Schallawitz R; Schallawitz S
Z Gesamte Inn Med; 1970 Aug; 25(15):700-4. PubMed ID: 5527535
[No Abstract] [Full Text] [Related]
7. [Insulin resistance and atherosclerosis. Controlling diabetes on 2 fronts].
MMW Fortschr Med; 2003 Sep; 145(37):65. PubMed ID: 14584452
[No Abstract] [Full Text] [Related]
8. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes.
von Bibra H; Hansen A; Dounis V; Bystedt T; Malmberg K; Rydén L
Heart; 2004 Dec; 90(12):1483-4. PubMed ID: 15547039
[No Abstract] [Full Text] [Related]
9. Platelet aggregation as a risk factor in diabetic subjects.
Krzywanek HJ; Breddin K
Horm Metab Res Suppl; 1981; 11():11-4. PubMed ID: 6459280
[No Abstract] [Full Text] [Related]
10. [Diabetic angiopathy. (Etiopathogenic concepts and prophylactic consequences)].
Mincu I; Câmpeanu S
Med Interna (Bucur); 1973 Feb; 25(2):147-56. PubMed ID: 4793921
[No Abstract] [Full Text] [Related]
11. [Treatment of type I diabetes: old limitations and new challenges].
Gómez-Huelgas R;
Rev Clin Esp; 2012 Sep; 212(8):389-90. PubMed ID: 22784800
[No Abstract] [Full Text] [Related]
12. Role for insulin in acute myocardial infarction: ruled out or hard to prove?
van der Horst IC; Zijlstra F
Eur Heart J; 2005 Dec; 26(23):2600. PubMed ID: 16227308
[No Abstract] [Full Text] [Related]
13. [Hypoglycemic medications and vascular complications of diabetes mellitus. Current controversy].
Lubetzki J
Rev Prat; 1976 Oct; 26(45):3173-83. PubMed ID: 981918
[No Abstract] [Full Text] [Related]
14. Glucose, insulin, and acute myocardial infarction.
Das UN
Eur Heart J; 2006 Sep; 27(17):2141-2; author reply 2142-3. PubMed ID: 16908489
[No Abstract] [Full Text] [Related]
15. Metabolic control of diabetes and vascular disease.
Raheja BS
J Assoc Physicians India; 1976 Oct; 24(10):687-99. PubMed ID: 828904
[No Abstract] [Full Text] [Related]
16. New advances in the management of insulin resistance in type 2 diabetes. Introduction.
Campbell IW; Charbonnel B
Int J Clin Pract Suppl; 2001 Sep; (121):3. PubMed ID: 11594242
[No Abstract] [Full Text] [Related]
17. The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.
Dandona P; Aljada A; Chaudhuri A; Bandyopadhyay A
J Clin Endocrinol Metab; 2003 Jun; 88(6):2422-9. PubMed ID: 12788837
[No Abstract] [Full Text] [Related]
18. [Insulin sensitizers is now approved as monotherapy as well. Lowering blood pressure with added effects].
MMW Fortschr Med; 2003 Oct; 145(41):47. PubMed ID: 14655486
[No Abstract] [Full Text] [Related]
19. [Structural-functional changes in biomembranes during complications of diabetes mellitus and their pharmacological correction].
Tat'ianenko LV; Bogdanov GN; Varfolomeev VN; Kotel'nikova RA; Shaposhnikova GI; Smirnov LD
Vopr Med Khim; 1998; 44(6):551-8. PubMed ID: 10599141
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P
Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
